AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine | Read

  • 2:21
  • Published On: July 19, 2020
Cinema View
Embed
The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
August 22, 2023 1:33
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
April 22, 2023 1:07
World's 1st Covid Nasal Vaccine Out On Republic Day
January 26, 2023 8:39
India Gets Its Own Nasal Vaccine, Booster Costs Rs. 800 Per Dose
January 26, 2023 1:18
"Isolated Events Can't Dent India's Image": Adar Poonawalla To NDTV
January 17, 2023 2:05
"We Are Trying To Engage With China": Adar Poonawalla To NDTV
January 17, 2023 1:27
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination